Hemorheological abnormalities in experimental cerebral ischemia and effects of protein kinase inhibitor on blood fluidity

Life Sciences

Volumn 67, Issue 16, 2000, Pages 1929-1939

  Hitomi, Asako ^a   Satoh, Shin ichi ^a   Ikegaki, Ichiro ^a   Suzuki, Yoshio ^b   Shibuya, Masato ^c   Asano, Toshio ^a  

^a ASAHI CHEMICAL INDUSTRY CO   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c CHUKYO HOSPITAL   (Japan)

Author keywords

Blood viscosity; Cerebral ischemia; Fasudil; Protein kinase inhibitor

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; FASUDIL; NIMODIPINE; OZAGREL; PROTEIN KINASE INHIBITOR; RHO KINASE; THROMBOXANE SYNTHASE INHIBITOR;

ABDOMINAL AORTA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD RHEOLOGY; BLOOD VISCOSITY; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG EFFECT; HEMODILUTION; MALE; MIDDLE CEREBRAL ARTERY; NONHUMAN; RAT; SHEAR RATE; SHEAR STRESS;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; ANIMALS; ARTERIAL OCCLUSIVE DISEASES; BLOOD VISCOSITY; CALCIUM CHANNEL BLOCKERS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; ERYTHROCYTES; HEMATOCRIT; HEMODILUTION; ISCHEMIC ATTACK, TRANSIENT; MALE; METHACRYLATES; MIDDLE CEREBRAL ARTERY; NIMODIPINE; PROTEIN KINASE INHIBITORS; RATS; RATS, WISTAR; THROMBOXANE-A SYNTHASE;

EID: 0034622967     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(00)00781-5     Document Type: Article

References (37)

1. The effects of calcium channel blockers on blood fluidity
2. Chronic blood hyperviscosity in subjects with acute stroke, transient ischemic attack, and risk factors for stroke
3. High blood viscosity syndrome in cerebral infarction
4. Effects of TCV-3B(Vinpocetine) on blood viscosity in ischemic cerebrovascular diseases
5. Mechanism of action of a novel antivasospasm drug, HA1077
6. Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage
7. Possible prophylactic potential of HA1077, a Ca2+ antagonist and vasodilator, on chronic cerebral vasospasm
8. Fasudil, a protein kinase inhibitor, prevents the development of endothelial injury and neutrophil infiltration in a two-haemorrhage canine model
9. Thromboxane A2 synthetase inhibitor failed to ameliorate the arterial narrowing during the chronic phase of cerebral vasospasm
10. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension
11. Selective inhibition of myosin phosphorylation and tension of hyperplastic arteries by the kinase inhibitor HA 1077
12. Vasodilator actions of HA1077 in vitro and in vivo putatively mediated by the inhibiton of protein kinase
13. The effects of HA1077, a novel protein kinase inhibitor, on reductions of cerebral blood flow and glucose metabolism following acute and/or chronic bilateral carotid artery ligation in Wistar rats
14. Blockade of intracellular actions of calcium may protect against ischaemic damage to the gerbil brain
15. Neuroprotective properties of a protein kinase inhibitor against ischaemia-induced neuronal damage in rats and gerbils
16. Optimum degree of hemodilution for brain protection in a canine model of focal cerebral ischemia
17. A new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area
18. Correlation between cerebral blood flow and histologic changes in a new rat model of middle cerebral artery occlusion
19. Effect of recirculation on exacerbation of ischemic vascular lesions in rat brain
20. Influx of leukocytes and platelets in an evolving brain infarct (Wistar rat)
21. Changes in blood viscosiy following nifedipine administration and its relation to the contents of adenosine triphosphate and 2,3-diphosphoglyceric acid in red blood cells in patients with angina pectoris
22. Pretreatment of transient focal cerebral ischemia in rats with the calcium antagonist AT877
23. Rho-kinase in human neutrophils: A role in signalling for myosin light chain phosphorylation and cell migration
24. Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase
25. Inhibiton of neutrophil migration by a protein kinase inhibitor for the treatment of ischemic brain infarction
26. Blood rheology, haemostasis and vascular disease
27. Failure to demonstrate beneficial effect of prostacyclin (PGI2) infusion on red blood cell deformability in patients with peripheral vascular disease: A possible role of the leukocytes
28. Nitric oxide from polymorhonuclear leukocytes modulates red blood cell deformability in vitro
29. Participation of serum albumin and LDL-cholesterol in impaired blood cell-filterability affected by white blood cells in patients with cerebral thrombosis
30. Activated polymorphonuclear leukocytes affect red blood cell aggregability
31. Inhibition by the protein kinase inhibitor HA 1077 of the activation of NADPH oxidase in human neutrophils
32. Calcium modulation and clinical effect profile of cyclandelate
33. Metabolic dependence of red cell deformability
34. Effects of thromboxane synthetase inhibitors on aggregation of rabbit platelets
35. Pharmacological studies on the TXA2 synthetase Inhibitor (E)-3-[p-(1H-imidazol-1-ylmethyl)phenyl]-2-propenoic acid (OKY-046)
36. Post-treatment of transient focal cerebral ischemia in rats with the novel cerebrovascular-selective Ca2+ channel antagonist (±)-(E)-1-(3-Fluoro-6,11-dihydrodibenz[b,e]-oxepine-11-yl)-4-(3-phenyl-2-pro penyl)-piperazine dimaleate